NCT00423865 Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00423852 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Status COMPLETED Phase PHASE1/PHASE2
NCT00423514 Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00422344 A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT00421512 A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients Status COMPLETED Phase PHASE1
NCT00416351 Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment Status COMPLETED Phase PHASE1/PHASE2
NCT00410956 Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00398138 Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma Status COMPLETED Phase PHASE1
NCT00398073 Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT00397904 Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin Status COMPLETED Phase PHASE2
NCT00397488 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium Status COMPLETED Phase PHASE2
NCT00393783 Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00390416 Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00387959 Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00382200 Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes Status COMPLETED Phase PHASE1/PHASE2
NCT00375518 Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery Status COMPLETED Phase NA
NCT00357396 Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors Status COMPLETED Phase PHASE2
NCT00354679 Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE2